HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-NOV-13 4NKA TITLE CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE TITLE 2 DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-765); COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, ATP BINDING, PHOSPHORYLATION, TRANS-MEMBRANE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,T.KLEIN REVDAT 3 28-FEB-24 4NKA 1 REMARK SEQADV REVDAT 2 16-JUL-14 4NKA 1 JRNL REVDAT 1 18-DEC-13 4NKA 0 JRNL AUTH T.KLEIN,J.TUCKER,G.A.HOLDGATE,R.A.NORMAN,A.L.BREEZE JRNL TITL FGFR1 KINASE INHIBITORS: CLOSE REGIOISOMERS ADOPT DIVERGENT JRNL TITL 2 BINDING MODES AND DISPLAY DISTINCT BIOPHYSICAL SIGNATURES. JRNL REF ACS MED CHEM LETT V. 5 166 2014 JRNL REFN ISSN 1948-5875 JRNL PMID 24900792 JRNL DOI 10.1021/ML4004205 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 37902 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1894 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.57 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2826 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2449 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2683 REMARK 3 BIN R VALUE (WORKING SET) : 0.2445 REMARK 3 BIN FREE R VALUE : 0.2520 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.06 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4338 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 216 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.79500 REMARK 3 B22 (A**2) : -14.37940 REMARK 3 B33 (A**2) : 7.58440 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.47750 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.214 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4566 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6231 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1532 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 107 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 650 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4566 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 575 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5092 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.87 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|464 - A|765 } REMARK 3 ORIGIN FOR THE GROUP (A): 80.5910 -2.5122 17.8126 REMARK 3 T TENSOR REMARK 3 T11: -0.3280 T22: 0.0616 REMARK 3 T33: -0.3670 T12: 0.0371 REMARK 3 T13: -0.0105 T23: 0.0497 REMARK 3 L TENSOR REMARK 3 L11: 2.5451 L22: 0.3836 REMARK 3 L33: 1.2247 L12: -0.4041 REMARK 3 L13: -0.5423 L23: 0.0225 REMARK 3 S TENSOR REMARK 3 S11: 0.1347 S12: 0.1844 S13: 0.2689 REMARK 3 S21: -0.1082 S22: -0.0516 S23: -0.0016 REMARK 3 S31: -0.1481 S32: 0.0208 S33: -0.0831 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|458 - B|765 } REMARK 3 ORIGIN FOR THE GROUP (A): 34.3533 1.5784 14.4177 REMARK 3 T TENSOR REMARK 3 T11: -0.3478 T22: 0.0467 REMARK 3 T33: -0.3772 T12: 0.0066 REMARK 3 T13: -0.0404 T23: -0.0196 REMARK 3 L TENSOR REMARK 3 L11: 3.5817 L22: 1.0827 REMARK 3 L33: 1.2579 L12: -0.9633 REMARK 3 L13: 0.1374 L23: 0.4056 REMARK 3 S TENSOR REMARK 3 S11: 0.1917 S12: 0.4628 S13: -0.3010 REMARK 3 S21: 0.1679 S22: -0.2802 S23: 0.1230 REMARK 3 S31: 0.1524 S32: 0.0494 S33: 0.0885 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NKA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000083309. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37902 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 46.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.44600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-20% PEG 8000, 100MM PCTP, 200MM REMARK 280 AMMONIUM SULFATE, 25% ETHYLENE GLYCOL, PH 6.75, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.41500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.68000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.41500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.68000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1015 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 490 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 LEU A 644 REMARK 465 ALA A 645 REMARK 465 ARG A 646 REMARK 465 ASP A 647 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 HIS A 650 REMARK 465 GLY B 457 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLY B 643 REMARK 465 LEU B 644 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 LEU A 465 CG CD1 CD2 REMARK 470 ARG A 470 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 LYS A 502 CG CD CE NZ REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 514 CG CD CE NZ REMARK 470 LEU A 516 CG CD1 CD2 REMARK 470 LYS A 517 CE NZ REMARK 470 SER A 518 OG REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 MET A 534 CE REMARK 470 LYS A 542 CE NZ REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 ARG A 622 CD NE CZ NH1 NH2 REMARK 470 ILE A 651 CG1 CG2 CD1 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 LYS A 656 CG CD CE NZ REMARK 470 THR A 658 OG1 CG2 REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CD CE NZ REMARK 470 LYS A 714 CE NZ REMARK 470 SER A 762 OG REMARK 470 VAL B 460 CG1 CG2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 ILE B 498 CG1 CG2 CD1 REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 LYS B 502 CG CD CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 510 NZ REMARK 470 LYS B 523 CD CE NZ REMARK 470 MET B 534 CE REMARK 470 LYS B 540 CG CD CE NZ REMARK 470 LYS B 542 CD CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 HIS B 649 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 650 CG ND1 CD2 CE1 NE2 REMARK 470 ILE B 651 CG1 CG2 CD1 REMARK 470 TYR B 654 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 655 CD CE NZ REMARK 470 THR B 658 OG1 CG2 REMARK 470 LYS B 711 CE NZ REMARK 470 LYS B 714 CE NZ REMARK 470 MET B 731 CG SD CE REMARK 470 LYS B 748 CG CD CE NZ REMARK 470 GLN B 764 CG CD OE1 NE2 REMARK 470 GLU B 765 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 593 -177.26 -64.72 REMARK 500 ARG A 622 -22.49 80.47 REMARK 500 VAL B 460 -7.52 68.33 REMARK 500 ASP B 468 88.34 -151.98 REMARK 500 ARG B 622 -21.71 79.69 REMARK 500 HIS B 650 -37.44 -148.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2K7 A 805 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2K7 B 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F63 RELATED DB: PDB REMARK 900 RELATED ID: 4F64 RELATED DB: PDB REMARK 900 RELATED ID: 4F65 RELATED DB: PDB REMARK 900 RELATED ID: 4NK9 RELATED DB: PDB REMARK 900 RELATED ID: 4NKS RELATED DB: PDB DBREF 4NKA A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4NKA B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4NKA GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 4NKA ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NKA SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4NKA GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 4NKA ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NKA SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET SO4 A 801 5 HET SO4 A 802 5 HET EDO A 803 4 HET EDO A 804 4 HET 2K7 A 805 32 HET SO4 B 801 5 HET EDO B 802 4 HET 2K7 B 803 32 HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM 2K7 N~4~-{3-[2-(3,4-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5- HETNAM 2 2K7 YL}-N~2~-[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]PYRIMIDINE- HETNAM 3 2K7 2,4-DIAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 SO4 3(O4 S 2-) FORMUL 5 EDO 3(C2 H6 O2) FORMUL 7 2K7 2(C22 H25 N7 O3) FORMUL 11 HOH *216(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ARG A 576 1 9 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 LEU A 662 MET A 667 5 6 HELIX 7 7 ALA A 668 ARG A 675 1 8 HELIX 8 8 THR A 678 THR A 695 1 18 HELIX 9 9 PRO A 705 GLU A 715 1 11 HELIX 10 10 THR A 726 TRP A 737 1 12 HELIX 11 11 VAL A 740 ARG A 744 5 5 HELIX 12 12 THR A 746 THR A 761 1 16 HELIX 13 13 PRO B 474 ASP B 476 5 3 HELIX 14 14 THR B 521 GLY B 539 1 19 HELIX 15 15 ASN B 568 ARG B 576 1 9 HELIX 16 16 SER B 596 LYS B 617 1 22 HELIX 17 17 ALA B 625 ARG B 627 5 3 HELIX 18 18 LEU B 662 MET B 667 5 6 HELIX 19 19 ALA B 668 ARG B 675 1 8 HELIX 20 20 THR B 678 THR B 695 1 18 HELIX 21 21 PRO B 705 GLU B 715 1 11 HELIX 22 22 THR B 726 TRP B 737 1 12 HELIX 23 23 VAL B 740 ARG B 744 5 5 HELIX 24 24 THR B 746 THR B 761 1 16 SHEET 1 A 5 LEU A 478 GLY A 485 0 SHEET 2 A 5 VAL A 492 ILE A 498 -1 O LEU A 494 N LYS A 482 SHEET 3 A 5 VAL A 508 MET A 515 -1 O VAL A 511 N ALA A 495 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 GLU B 486 0 SHEET 2 C 5 GLY B 490 ILE B 498 -1 O VAL B 492 N LEU B 484 SHEET 3 C 5 VAL B 508 LEU B 516 -1 O VAL B 511 N ALA B 495 SHEET 4 C 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 8 ARG A 570 ARG A 627 THR A 657 ASN A 659 SITE 2 AC1 8 ARG A 661 TRP A 666 HOH A 915 HOH A 990 SITE 1 AC2 4 GLY A 539 LYS A 540 LYS A 618 HOH A 987 SITE 1 AC3 5 ALA A 615 THR A 746 PHE A 747 LYS A 748 SITE 2 AC3 5 HOH A 933 SITE 1 AC4 6 TRP A 684 TYR A 701 ARG A 718 MET A 719 SITE 2 AC4 6 TRP A 737 HOH A 919 SITE 1 AC5 10 LEU A 484 ALA A 512 GLU A 531 GLU A 562 SITE 2 AC5 10 TYR A 563 ALA A 564 GLY A 567 ARG A 627 SITE 3 AC5 10 LEU A 630 ASP A 641 SITE 1 AC6 6 ARG B 570 ARG B 627 THR B 657 ASN B 659 SITE 2 AC6 6 ARG B 661 HOH B 901 SITE 1 AC7 6 TYR B 701 LEU B 713 ARG B 718 MET B 719 SITE 2 AC7 6 TRP B 737 HOH B 963 SITE 1 AC8 11 LEU B 484 ALA B 512 LYS B 514 GLU B 531 SITE 2 AC8 11 VAL B 561 GLU B 562 TYR B 563 ALA B 564 SITE 3 AC8 11 ARG B 627 LEU B 630 ASP B 641 CRYST1 208.830 57.360 65.730 90.00 107.68 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004789 0.000000 0.001526 0.00000 SCALE2 0.000000 0.017434 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015968 0.00000